Company: IPODW
Filing Date: 2025-03-07
Form Type: S-1
Source: 0001213900-25-021721
Chunk: 313

Company: Dune Acquisition Corp II
Filing Date: 2025-03-07
Form: S-1
Chunk 313
---
us, and, once the Class A ordinary shares and warrants begin separate trading, to have our Class A ordinary shares and warrants listed on Nasdaq under the symbols “IPOD” and “IPODW,” respectively. We cannot guarantee that our securities will be approved for listing on Nasdaq. Discounts The following table shows the underwriting discounts and commissions that we are to pay to the underwriters in connection with this offering. These amounts are shown assuming both no exercise and full exercise of the underwriters’ over -allotmentoption.

|                                                    |     | Per Unit       
 Without        
 Over-allotment |      |     | With           
 Over-allotment |      |     | Total          
 Without        
 Over-allotment |           |     | With           
 Over-allotment |           |
|:---------------------------------------------------|:----|:---------------|-----:|:----|:---------------|-----:|:----|:---------------|----------:|:----|:---------------|----------:|
| Underwriting Discounts and Commissions paid by us: |     | $              | 0.45 |     | $              | 0.45 |     | $              | 6,750,000 |     | $              | 7,762,500 |

Includes (A) $00.05 per unit sold in the offering, or $750,000 in the aggregate, payable to the underwriters upon the closing of this offering (or $862,500 if the over -allotmentoption is exercised in full); and (B) up to $0.40 per unit, or up to $6,000,000 in the aggregate (or up to $6,900,000 if the overallotment option is exercised in full), payable to the underwriters in this offering, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination, but such $0.40 per unit shall be due solely on amounts remaining in the trust account following all properly submitted shareholder redemptions in connection with the consummation of our initial business combination. In addition, we have agreed to issue to the representative of the underwriters or its designee an aggregate of 112,500 Class A ordinary shares (or up to 129,375 Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full), as part of representative compensation, which will be issued upon the consumm